Cytokeratin 18 cell death assays as biomarkers for quantification of apoptosis and necrosis in COVID-19: a prospective, observational study

Background The mechanism by which SARS-CoV-2 triggers cell damage and necrosis are yet to be fully elucidated. We sought to quantify epithelial cell death in patients with COVID-19, with an estimation of relative contributions of apoptosis and necrosis. Methods Blood samples were collected prospectively from adult patients presenting to the emergency department. Circulating levels of caspase-cleaved (apoptosis) and total cytokeratin 18 (CK-18) (total cell death) were determined using M30 and M65 enzyme assays, respectively. Intact CK-18 (necrosis) was estimated by subtracting M30 levels from M65. Results A total of 52 COVID-19 patients and 27 matched sick controls (with respiratory symptoms not due to COVID-19) were enrolled. Compared with sick controls, COVID-19 patients had higher levels of M65 (p = 0.046, total cell death) and M30 (p = 0.0079, apoptosis). Hospitalised COVID-19 patients had higher levels of M65 (p= 0.014) and intact CK-18 (p= 0.004, necrosis) than discharged patients. Intensive care unit (ICU)-admitted COVID-19 patients had higher levels of M65 (p= 0.004), M30 (p= 0.004) and intact CK-18 (p= 0.033) than hospitalised non-ICU admitted patients. In multivariable logistic regression, elevated levels of M65, M30 and intact CK-18 were associated with increased odds of ICU admission (OR=22.05, p=0.014, OR=19.71, p=0.012 and OR=14.12, p=0.016, respectively). Conclusion Necrosis appears to be the main driver of hospitalisation, whereas apoptosis and necrosis appear to drive ICU admission. Elevated levels CK-18 levels are independent predictors of severe disease, and could be useful for risk stratification of COVID-19 patients and in assessment of therapeutic efficacy in early-phase COVID-19 clinical trials.

[1]  Peng Zhou,et al.  SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation , 2020, Signal Transduction and Targeted Therapy.

[2]  G. Lippi,et al.  Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis , 2020, Acta bio-medica : Atenei Parmensis.

[3]  I. Cheruiyot,et al.  Arterial Thrombosis in Coronavirus Disease 2019 Patients: A Rapid Systematic Review , 2020, Annals of Vascular Surgery.

[4]  I. Adcock,et al.  The Immune Response and Immunopathology of COVID-19 , 2020, Frontiers in Immunology.

[5]  Ashutosh Kumar,et al.  Histopathological observations in COVID-19: a systematic review , 2020, Journal of Clinical Pathology.

[6]  G. Lippi,et al.  False negative RT-PCR or false positive serological testing in SARS-CoV-2 diagnostics? Navigating between Scylla and Charybdis to prevent misclassification bias in COVID-19 clinical investigations , 2020, Diagnosis.

[7]  J. Lacy,et al.  Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series , 2020, The Lancet.

[8]  A. Allegra,et al.  Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies , 2020, Annals of Hematology.

[9]  F. Burel-Vandenbos,et al.  Pericyte alteration sheds light on micro-vasculopathy in COVID-19 infection , 2020, Intensive Care Medicine.

[10]  Xiang Chen,et al.  Association of inflammatory markers with the severity of COVID-19: A meta-analysis , 2020, International Journal of Infectious Diseases.

[11]  D. Gommers,et al.  Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis , 2020, Thrombosis Research.

[12]  R. José,et al.  COVID-19 cytokine storm: the interplay between inflammation and coagulation , 2020, The Lancet Respiratory Medicine.

[13]  E. Göttgens,et al.  Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing , 2020, medRxiv.

[14]  D. Gommers,et al.  Incidence of thrombotic complications in critically ill ICU patients with COVID-19 , 2020, Thrombosis Research.

[15]  A. Zangrillo,et al.  Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis , 2020, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[16]  J. Zhao,et al.  Cytokeratin 18 regulates the transcription and alternative splicing of apoptotic-related genes and pathways in HeLa cells , 2019, Oncology reports.

[17]  F. Tacke,et al.  High Circulating Caspase-Cleaved Keratin 18 Fragments (M30) Indicate Short-Term Mortality in Critically Ill Patients , 2018, Disease markers.

[18]  J. Solé-Violán,et al.  Serum Levels of Caspase-Cleaved Cytokeratin-18 and Mortality Are Associated in Severe Septic Patients: Pilot Study , 2014, PloS one.

[19]  H. Zhu,et al.  Cytokeratin 18 Is Not Required for Morphogenesis of Developing Prostates but Contributes to Adult Prostate Regeneration , 2013, BioMed research international.

[20]  F. Chan,et al.  Detection of necrosis by release of lactate dehydrogenase activity. , 2013, Methods in molecular biology.

[21]  Yun Cui,et al.  Biological Functions of Cytokeratin 18 in Cancer , 2012, Molecular Cancer Research.

[22]  E. D. de Vries,et al.  Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer. , 2008, Neoplasia.

[23]  K. Lee,et al.  Evaluation of bronchoalveolar lavage fluid from ARDS patients with regard to apoptosis. , 2008, Respiratory medicine.

[24]  S. Linder,et al.  Cytokeratin-18 Is a Useful Serum Biomarker for Early Determination of Response of Breast Carcinomas to Chemotherapy , 2007, Clinical Cancer Research.

[25]  L. Doughty,et al.  In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice. , 2005, Blood.

[26]  I. Chaudry,et al.  Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity , 2003, Journal of leukocyte biology.

[27]  Chulhee Choi,et al.  Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Induces Caspase-Dependent Interleukin-8 Expression and Apoptosis in Human Astroglioma Cells , 2002, Molecular and Cellular Biology.

[28]  R. Hotchkiss,et al.  Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte , 2000, Nature Immunology.